Discover 2,391 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
From paid studies for healthy volunteers to condition-specific trials, North Carolina offers a wide range of clinical research opportunities. Leading medical centers in Charlotte, Raleigh, and Durham are seeking participants, providing access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 2,391
Active & Responsive
Oxygen Toxicity: Mechanisms in Humans
for
Oxygen Toxicity, Hypercapnia, Seizures
Location: 1 recruiting location
Sponsor: Duke University
Sex: All
Age: 18 - 45
Code: NCT05761756
Recruiting
Active & Responsive
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
for
Relapsing Multiple Sclerosis (RMS)
Location: 61 recruiting locations
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06869785
Phase3, Recruiting
Active & Responsive
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
for
PTSD
Location: 11 recruiting locations
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05457985
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
for
Alzheimer Disease, Dementia
Location: 29 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 55 - 70+
Code: NCT06721156
Phase2, Recruiting
Active & Responsive
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
for
Cystic Fibrosis
Location: 5 recruiting locations
Sponsor: Krystal Biotech, Inc.
Sex: All
Age: 18+
Code: NCT05504837
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
for
Non-Hodgkin Lymphoma
Location: 6 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05169515
Phase1, Recruiting
Active & Responsive
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
for
Advanced Solid Tumor
Location: 6 recruiting locations
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06750185
Phase1, Recruiting
Active & Responsive
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
for
Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Location: 4 recruiting locations
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05853575
Phase2, Recruiting
Active & Responsive
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
for
Propionic Acidemia
Location: 7 recruiting locations
Sponsor: ModernaTX, Inc.
Sex: All
Age: 1+
Code: NCT05130437
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study
for
Multiple System Atrophy
Location: 16 recruiting locations
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.